Full Text View
Tabular View
No Study Results Posted
Related Studies
Long-Term Treatment Study of MRA for Systemic Juvenile Idiopathic Arthritis (sJIA)
This study is ongoing, but not recruiting participants.
Study NCT00144612   Information provided by Chugai Pharmaceutical
First Received: September 2, 2005   Last Updated: June 15, 2009   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Additional conditions recognized in this trial
Arthritis
Arthritis, Juvenile Rheumatoid
More general conditions related to this trial
Arthritis, Rheumatoid
Autoimmune Diseases
Connective Tissue Diseases
Immune System Diseases
Joint Diseases
Musculoskeletal Diseases
Rheumatic Diseases
Interventions listed in this trial
MRA(Tocilizumab)
Sponsors listed in this trial
Chugai Pharmaceutical


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services